Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies.

Brewer, Jamie R; Chang, Elaine; Agrawal, Sundeep; Singh, Harpreet; Suzman, Daniel L; Xu, James; Weinstock, Chana; Fernandes, Laura L; Cheng, Joyce; Zhang, Lijun; Xie, Diqiong; Goldberg, Kirsten B; Bloomquist, Erik W; Tang, Shenghui; Sridhara, Rajeshwari; Theoret, Marc R; Pazdur, Richard; Ibrahim, Amna; Beaver, Julia A

Brewer, Jamie R; Chang, Elaine; Agrawal, Sundeep; Singh, Harpreet; Suzman, Daniel L; Xu, James; Weinstock, Chana; Fernandes, Laura L; Cheng, Joyce; Zhang, Lijun; Xie, Diqiong; Goldberg, Kirsten B; Bloomquist, Erik W; Tang, Shenghui; Sridhara, Rajeshwari; Theoret, Marc R; Pazdur, Richard; Ibrahim, Amna; Beaver, Julia A.

Affiliation

Brewer JR; U.S. Food and Drug Administration, White Oak, Maryland. Jamie.Brewer@fda.hhs.gov.
Chang E; U.S. Food and Drug Administration, White Oak, Maryland.
Agrawal S; U.S. Food and Drug Administration, White Oak, Maryland.
Singh H; U.S. Food and Drug Administration, White Oak, Maryland.
Suzman DL; U.S. Food and Drug Administration, White Oak, Maryland.
Xu J; U.S. Food and Drug Administration, White Oak, Maryland.
Weinstock C; U.S. Food and Drug Administration, White Oak, Maryland.
Fernandes LL; U.S. Food and Drug Administration, White Oak, Maryland.
Cheng J; U.S. Food and Drug Administration, White Oak, Maryland.
Zhang L; U.S. Food and Drug Administration, White Oak, Maryland.
Xie D; U.S. Food and Drug Administration, White Oak, Maryland.
Goldberg KB; U.S. Food and Drug Administration, White Oak, Maryland.
Bloomquist EW; U.S. Food and Drug Administration, White Oak, Maryland.
Tang S; U.S. Food and Drug Administration, White Oak, Maryland.
Sridhara R; U.S. Food and Drug Administration, White Oak, Maryland.
Theoret MR; U.S. Food and Drug Administration, White Oak, Maryland.
Pazdur R; U.S. Food and Drug Administration, White Oak, Maryland.
Ibrahim A; U.S. Food and Drug Administration, White Oak, Maryland.
Beaver JA; U.S. Food and Drug Administration, White Oak, Maryland.

Clin Cancer Res ; 26(24): 6406-6411, 2020 12 15.

Article de En | MEDLINE | ID: mdl-32732222

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Protocoles de polychimiothérapie antinéoplasique / Agrément de médicaments / Association médicamenteuse / Développement de médicament / Tumeurs du rein Type d'étude: Clinical_trials / Prognostic_studies Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google